Safety Assessment of Microsilver-loaded Poly(methyl Methacrylate) (PMMA) Cement Spacers in Patients with Prosthetic Hip Infections: Results of a Prospective Cohort Study

Overview

Journal Bone Joint Res

Date 2019 Sep 21

PMID 31537996

Citations 7

Authors

Volker Alt

Markus Rupp

Karsten Lemberger

Thorsten Bechert

Thomas Konradt

Peter Steinrucke

Reinhard Schnettler

Stephan Soder

Rudolf Ascherl

Affiliations

Soon will be listed here.

Abstract

Objectives: Preclinical data showed poly(methyl methacrylate) (PMMA) loaded with microsilver to be effective against a variety of bacteria. The purpose of this study was to assess patient safety of PMMA spacers with microsilver in prosthetic hip infections in a prospective cohort study.

Methods: A total of 12 patients with prosthetic hip infections were included for a three-stage revision procedure. All patients received either a gentamicin-PMMA spacer (80 g to 160 g PMMA depending on hip joint dimension) with additional loading of 1% (w/w) of microsilver (0.8 g to 1.6 g per spacer) at surgery 1 followed by a gentamicin-PMMA spacer without microsilver at surgery 2 or vice versa. Implantation of the revision prosthesis was carried out at surgery 3.

Results: In total, 11 of the 12 patients completed the study. No argyria or considerable differences in laboratory parameters were detected. Silver blood concentrations were below or around the detection limit of 1 ppb in ten of the 11 patients. A maximum of 5.6 ppb at 48 hours after implantation of the silver spacer, which is below the recommended maximum level of 10 ppb, was found in one patient. No silver was detected in the urine. Drainage fluids showed concentrations between 16.1 ppb and 23.3 ppb at 12 hours after implantation of the silver spacers, and between 16.8 ppb to 25.1 ppb at 48 hours after implantation. Pathohistological assessment of the periprosthetic membrane did not reveal any differences between the two groups.

Conclusion: Microsilver-loaded gentamicin-PMMA spacers showed good biocompatibility and the broad antimicrobial activity warrants further clinical research to assess its effectivity in reducing infection rates in prosthetic joint infection.: V. Alt, M. Rupp, K. Lemberger, T. Bechert, T. Konradt, P. Steinrücke, R. Schnettler, S. Söder, R. Ascherl. Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study. 2019;8:387-396. DOI: 10.1302/2046-3758.88.BJR-2018-0270.R1.

Citing Articles

What to Know about Antimicrobial Coatings in Arthroplasty: A Narrative Review.

Onorato F, Masoni V, Gagliardi L, Comba L, Rivera F Medicina (Kaunas). 2024; 60(4).

PMID: 38674220 PMC: 11052078. DOI: 10.3390/medicina60040574.

Physical, Mechanical, and Biological Properties of PMMA-Based Composite Bone Cement Containing Silver-Doped Bioactive and Antibacterial Glass Particles with Different Particles Sizes.

Miola M, Lucchetta G, Verne E Materials (Basel). 2023; 16(13).

PMID: 37444813 PMC: 10342656. DOI: 10.3390/ma16134499.

The sternum reconstruction: Present and future perspectives.

Aramini B, Masciale V, Radaelli L, Sgarzani R, Dominici M, Stella F Front Oncol. 2022; 12:975603.

PMID: 36387077 PMC: 9649912. DOI: 10.3389/fonc.2022.975603.

Trabecular Titanium for Orthopedic Applications: Balancing Antimicrobial with Osteoconductive Properties by Varying Silver Contents.

Diez-Escudero A, Carlsson E, Andersson B, Jarhult J, Hailer N ACS Appl Mater Interfaces. 2022; 14(37):41751-41763.

PMID: 36069272 PMC: 9501801. DOI: 10.1021/acsami.2c11139.

Antimicrobial rationing in orthopaedic surgery.

Tsang S, Simpson A Bone Joint Res. 2020; 9(12):870-872.

PMID: 33307769 PMC: 9021903. DOI: 10.1302/2046-3758.912.BJR-2020-0521.

References

Neut D, van de Belt H, Stokroos I, van Horn J, van der Mei H, Busscher H . Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother. 2001; 47(6):885-91. DOI: 10.1093/jac/47.6.885. View

Thomes B, Murray P, Bouchier-Hayes D . Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. J Bone Joint Surg Br. 2002; 84(5):758-60. DOI: 10.1302/0301-620x.84b5.11907. View

Alt V, Bechert T, Steinrucke P, Wagener M, Seidel P, Dingeldein E . An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials. 2004; 25(18):4383-91. DOI: 10.1016/j.biomaterials.2003.10.078. View

Gosheger G, Hardes J, Ahrens H, Streitburger A, Buerger H, Erren M . Silver-coated megaendoprostheses in a rabbit model--an analysis of the infection rate and toxicological side effects. Biomaterials. 2004; 25(24):5547-56. DOI: 10.1016/j.biomaterials.2004.01.008. View

PERRELLI G, Piolatto G . Tentative reference values for gold, silver and platinum: literature data analysis. Sci Total Environ. 1992; 120(1-2):93-6. DOI: 10.1016/0048-9697(92)90219-i. View

Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W . Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma. 2006; 60(3):648-52. DOI: 10.1097/01.ta.0000208126.22089.b6. View

Morawietz L, Classen R, Schroder J, Dynybil C, Perka C, Skwara A . Proposal for a histopathological consensus classification of the periprosthetic interface membrane. J Clin Pathol. 2006; 59(6):591-7. PMC: 1860400. DOI: 10.1136/jcp.2005.027458. View

Hardes J, Ahrens H, Gebert C, Streitbuerger A, Buerger H, Erren M . Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials. 2007; 28(18):2869-75. DOI: 10.1016/j.biomaterials.2007.02.033. View

Vlachou E, Chipp E, Shale E, Wilson Y, Papini R, Moiemen N . The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. Burns. 2007; 33(8):979-85. DOI: 10.1016/j.burns.2007.07.014. View

10.

Morawietz L, Tiddens O, Mueller M, Tohtz S, Gansukh T, Schroeder J . Twenty-three neutrophil granulocytes in 10 high-power fields is the best histopathological threshold to differentiate between aseptic and septic endoprosthesis loosening. Histopathology. 2009; 54(7):847-53. DOI: 10.1111/j.1365-2559.2009.03313.x. View

11.

Hardes J, von Eiff C, Streitbuerger A, Balke M, Budny T, Henrichs M . Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol. 2010; 101(5):389-95. DOI: 10.1002/jso.21498. View

12.

Parvizi J, Zmistowski B, Adeli B . Periprosthetic joint infection: treatment options. Orthopedics. 2010; 33(9):659. DOI: 10.3928/01477447-20100722-42. View

13.

Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U . Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol. 2011; 8:18. PMC: 3123173. DOI: 10.1186/1743-8977-8-18. View

14.

Glehr M, Leithner A, Friesenbichler J, Goessler W, Avian A, Andreou D . Argyria following the use of silver-coated megaprostheses: no association between the development of local argyria and elevated silver levels. Bone Joint J. 2013; 95-B(7):988-92. DOI: 10.1302/0301-620X.95B7.31124. View

15.

Cooper H, Della Valle C . The two-stage standard in revision total hip replacement. Bone Joint J. 2013; 95-B(11 Suppl A):84-7. DOI: 10.1302/0301-620X.95B11.32906. View

16.

Citak M, Argenson J, Masri B, Kendoff D, Springer B, Alt V . Spacers. J Arthroplasty. 2013; 29(2 Suppl):93-9. DOI: 10.1016/j.arth.2013.09.042. View

17.

Helwig P, Morlock J, Oberst M, Hauschild O, Hubner J, Borde J . Periprosthetic joint infection--effect on quality of life. Int Orthop. 2014; 38(5):1077-81. PMC: 3997779. DOI: 10.1007/s00264-013-2265-y. View

18.

Marx D, Barillo D . Silver in medicine: the basic science. Burns. 2014; 40 Suppl 1:S9-S18. DOI: 10.1016/j.burns.2014.09.010. View

19.

Wafa H, Grimer R, Reddy K, Jeys L, Abudu A, Carter S . Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: case-control study. Bone Joint J. 2015; 97-B(2):252-7. DOI: 10.1302/0301-620X.97B2.34554. View

20.

Gomez M, Tan T, Manrique J, Deirmengian G, Parvizi J . The Fate of Spacers in the Treatment of Periprosthetic Joint Infection. J Bone Joint Surg Am. 2015; 97(18):1495-502. DOI: 10.2106/JBJS.N.00958. View